These variables include systemic corticosteroid use and inflammatory markers such as interleukin-6 (IL-6), c-reactive protein (CRP), and erythrocyte sedimentation rate (ESR), which all have associations between elevated levels and poor prognosis in brain tumor patients (57, 58). This evidence concerns the gene CRP and brain neoplasm.